BioSpace Announces Inaugural 40 Under 40 Winners
"These individuals demonstrate why the biopharma industry will continue to persevere—determination to improve health through innovation, creativity and leading with conviction," said
40 Under 40 winners hail from a range of therapeutic areas and business functions. The 2025 cohort winners are:
-
Tetiana Aleksandrova , CEO and Co-Founder, Subsense -
Kristen Anderson , Associate General Counsel,Verona Pharma - Nkiru Anyagaligbo, Digital Lead – Rare, Apellis
-
Andrew Barnhill , Head of Public Policy and Government Affairs, IQVIA -
Daniel Barvin , Vice President of Operations and Patient Advocacy, Coya Therapeutics -
Neena Bitritto-Garg , Founder, President and CEO, Ensho Therapeutics -
Francesco Borriello , Executive Director, Early-Stage Biology and Discovery Lead, Generate:Biomedicines -
Shelley Brathwaite , Director Patient Marketing Oncology, Sumitomo Pharma America -
Lena Ceballos , Manager, Corporate Communications and Marketing, Arcturus Therapeutics -
Alexandra Collin de l'Hortet, Vice President of Therapeutics, Epicrispr Biotechnologies -
Ashley Craddick , Senior Director of Operations for AAV Manufacturing, Forge Biologics -
David de Vries , Co-founder and CEO, Tr1x Bio -
Jacob Donoghue , CEO and Co-Founder, Beacon Biosignals -
William Eberley , Executive Director, Manufacturing Science and Technology, Vertex Pharmaceuticals -
Evan Feinberg , CEO,Genesis Therapeutics - Ye Fu, Co-Founder and Chief Scientific Officer, Stellaromics
- Fabian Gerlinghaus, CEO and Co-Founder, Cellares
- Peyton Greenside, CEO and Co-Founder, BigHat Biosciences
-
Michael Henderson , CEO, Apogee Therapeutics -
Katie Jorgensen , Vice President, Site Head, Basecamp, ElevateBio - Prineeta Kulkarni, Head of Strategy and Corporate Development,
Vedanta Biosciences -
Benjamine Liu , CEO and Co-Founder, Formation Bio -
Sean McClain , Founder and CEO, Absci -
Benjamin Oakes , CEO and Co-Founder, Scribe Therapeutics -
Kevin Parker , CEO and Co-Founder, Cartography Biosciences - Darshil Patel, Director of Research and Development, COUR
-
Dina Radenkovic , CEO and Co-Founder, Gameto -
Nabiha Saklayen , CEO and Co-Founder, Cellino Biotech -
Janine Sengstack , Co-Founder and Chief Scientific Officer, Junevity -
Ananth Sridhar , Chief Operating Officer, Cardiorenal, BridgeBio -
Benjamin Stone , Chief Business Officer, AnaptysBio -
Samantha Tabone ,General Partner ,XEIA Venture Partners ; Head of Business Development, Xylo Bio -
Hok Hei Tam , Chief Technology Officer,Montai Therapeutics ; Senior Principal,Flagship Pioneering -
Shilpa Tekula , Medical Director,Novartis Pharmaceuticals -
Alex Tilley , Senior Vice President, Advanced Analytics and Strategic Operations, BioCryst Pharmaceuticals -
Raphael Townshend , CEO and Founder, Atomic AI -
Tyler Van Horn , CEO,Science 37 -
Niels Vande Casteele , Vice President,Early Clinical Development and Pharmacology, Mirador Therapeutics -
Angela Yen , Vice President, Data and Computational Sciences, Vertex Pharmaceuticals -
Xiao Zhang , Head of Global Pipeline Commercialization and Strategy for Gastroenterology, AbbVie
About 40 Under 40
Nominations for 40 Under 40 were open from
About
View original content to download multimedia:https://www.prnewswire.com/news-releases/biospace-announces-inaugural-40-under-40-winners-302576150.html
SOURCE